Lifitegrast For Solution
Product Images NDC 59651-450

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Lifitegrast (NDC 59651-450). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Lifitegrast Ophthalmic Solution 5% Figure1 (Lifitegrast Fig1)

Lifitegrast Ophthalmic Solution 5% Figure1 (Lifitegrast Fig1)
FDA Label Image

Lifitegrast Ophthalmic Solution 5% Figure-10 (Lifitegrast Fig10)

Lifitegrast Ophthalmic Solution 5% Figure-10 (Lifitegrast Fig10)
FDA Label Image

Lifitegrast Ophthalmic Solution 5% Figure11 (Lifitegrast Fig11)

Lifitegrast Ophthalmic Solution 5% Figure11 (Lifitegrast Fig11)
This is an ophthalmic solution used for topical application to the eye. The usual dosage is one drop, twice a day in each eye. The solution comes in single-dose containers and should be used immediately after opening and then discarded. It should be stored at 20 to 25°C (68 to 77°F). The solution is sterile and preservative-free. Each package contains 5 single-dose containers of 0.2 mL each. The solution is distributed by Aurobindo Pharma USA, Inc. It is made in India.*
FDA Label Image

Lifitegrast Ophthalmic Solution 5% Figure12 (Lifitegrast Fig12)

Lifitegrast Ophthalmic Solution 5% Figure12 (Lifitegrast Fig12)
FDA Label Image

Lifitegrast Ophthalmic Solution 5% Figure2 (Lifitegrast Fig2)

Lifitegrast Ophthalmic Solution 5% Figure2 (Lifitegrast Fig2)
FDA Label Image

Lifitegrast Ophthalmic Solution 5% Figure-3 (Lifitegrast Fig3)

Lifitegrast Ophthalmic Solution 5% Figure-3 (Lifitegrast Fig3)
FDA Label Image

Lifitegrast Ophthalmic Solution 5% Figure-4 (Lifitegrast Fig4)

Lifitegrast Ophthalmic Solution 5% Figure-4 (Lifitegrast Fig4)
FDA Label Image

Lifitegrast Ophthalmic Solution 5% Figure-5 (Lifitegrast Fig5)

Lifitegrast Ophthalmic Solution 5% Figure-5 (Lifitegrast Fig5)
FDA Label Image

Lifitegrast Ophthalmic Solution 5% Figure-6 (Lifitegrast Fig6)

Lifitegrast Ophthalmic Solution 5% Figure-6 (Lifitegrast Fig6)
FDA Label Image

Lifitegrast Ophthalmic Solution 5% Figure-7 (Lifitegrast Fig7)

Lifitegrast Ophthalmic Solution 5% Figure-7 (Lifitegrast Fig7)
FDA Label Image

Lifitegrast Ophthalmic Solution 5% Figure-8 (Lifitegrast Fig8)

Lifitegrast Ophthalmic Solution 5% Figure-8 (Lifitegrast Fig8)
FDA Label Image

Lifitegrast Ophthalmic Solution 5% Figure-9 (Lifitegrast Fig9)

Lifitegrast Ophthalmic Solution 5% Figure-9 (Lifitegrast Fig9)
FDA Label Image

Lifitegrast Ophthalmic Solution 5% Figure1 (Lifitegrast Str)

Lifitegrast Ophthalmic Solution 5% Figure1 (Lifitegrast Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.